Abstract
SummaryAttention is called to discrepancies arising in mouse assays of botulinum toxin when the method of dilution and choice of diluent are not standardized. As much as 50-fold variation in the toxicity determinations resulted from the use of various diluents in the preparation of the serial dilution. Explanations of some of the discrepancies are suggested.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
